Latest news
Top Silexion Therapeutics Corp - Warrant (SLXNW) Competitors 2026 - MarketBeatMarketBeat · Sun, 09 Aug 2026 13:51:42 GMTSilexion Therapeutics publishes corporate deck spotlighting SIL204 siRNA program targeting KRAS-driven cancers - BitgetBitget · Sun, 09 Aug 2026 13:24:56 GMTSilexion Therapeutics (NASDAQ: SLXN) files S-1 for best-efforts unit sale - Stock TitanStock Titan · Fri, 07 Aug 2026 22:52:53 GMTSilexion Therapeutics Restores Nasdaq Audit Committee Compliance - TipRanksTipRanks · Mon, 03 Aug 2026 13:56:42 GMTSilexion Therapeutics Successfully Initiates Phase 2/3 - GlobeNewswireGlobeNewswire · Wed, 29 Jul 2026 11:00:00 GMTSilexion Opens Its First Pancreatic Cancer Trial Site in Israel - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMT